Top 19 NGM Biopharmaceuticals investors
The most complete profiles first. Showing 19 of 19.
David GoeddelVerified
Venture Capital, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
Peter SvennilsonVerified
Venture Capital, Founder, Private Equity Firm · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Verified email available
David SchnellVerified
Venture Capital · United States
Health CareWearablesGeneticsBiotechnologyPortfolio: Rejuvenon, Gloucester Pharmaceuticals, Visiogen, NGM Biopharmaceuticals and 40 more
Verified email available
Eric ThompsonVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
Habib KairouzVerified
Venture Capital, Private Equity Firm · United States
AdvertisingData IntegrationTelecommunicationsPaymentsPortfolio: True Office Learning, Travora Networks, Alien Technology, Gloucester Pharmaceuticals and 57 more
Verified email available
John AvirettVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
John WuestlingVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
Mark RoehrenbeckVerified
Venture Capital, Private Equity Firm · United States
AdvertisingData IntegrationTelecommunicationsPaymentsPortfolio: True Office Learning, Travora Networks, Alien Technology, Gloucester Pharmaceuticals and 57 more
Verified email available
Stephen WestVerified
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Verified email available
Tim Kutzkey
Venture Capital, Private Equity Firm, Investor · United States
SeedHealth CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
C. Ashton Newhall
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Deric Emry
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Douglas McCormick
Venture Capital, Private Equity Firm, Finance Operator · United States
AdvertisingData IntegrationTelecommunicationsPaymentsPortfolio: True Office Learning, Travora Networks, Alien Technology, Gloucester Pharmaceuticals and 57 more
Contact details available
JJ Kang
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
James Evangelista
Venture Capital · United States
Health CareWomen FoundedLife ScienceBiotechnologyPortfolio: Exonics Therapeutics, Remix Therapeutics, NGM Biopharmaceuticals, Constellation Pharmaceuticals and 31 more
Contact details available
Lindsay Redfield
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Martin Vogelbaum
Venture Capital, Private Equity Firm, Finance Operator · United States
AdvertisingData IntegrationTelecommunicationsPaymentsPortfolio: True Office Learning, Travora Networks, Alien Technology, Gloucester Pharmaceuticals and 57 more
Contact details available
Russell Hirsch
Venture Capital · United States
Health CareWearablesGeneticsBiotechnologyPortfolio: Rejuvenon, Gloucester Pharmaceuticals, Visiogen, NGM Biopharmaceuticals and 40 more
Contact details available
Todd Ruppert
Venture Capital, Secondary Purchaser, Fund Of Funds · United States
Health CareGeneticsCybersecurityDatabasesPortfolio: Namely, UserTesting, NGM Biopharmaceuticals, Xometry and 75 more
Contact details available
Frequently asked questions
How many NGM Biopharmaceuticals investors are on Angel Roster?
Angel Roster lists 19 NGM Biopharmaceuticals investors. 9 of them (47%) include a verified email address.
What types of investors are they?
The most common investor types are Venture Capital Firms (19), Funds of Funds (8) and Secondary Purchaser Investors (8). An investor can have more than one type, for example an angel who is also a venture partner.
Which stages do NGM Biopharmaceuticals investors invest in?
Among those that list a stage, the most common are Seed (3).
Where are NGM Biopharmaceuticals investors based?
Most are based in the United States (19).
Which companies have NGM Biopharmaceuticals investors backed?
The most-backed portfolio companies among them are Kallyope (13), Tenaya Therapeutics (13), Kareo (8), Phathom Pharmaceuticals (8) and MapR Technologies (8).
How do I contact NGM Biopharmaceuticals investors?
Create a free Angel Roster account to search and filter all 19, then unlock verified emails and LinkedIn profiles on a paid plan. Every plan starts with a 3-day free trial.